Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Microbiome companies look beyond the gut for new therapies

  • Kate Sheridan

By Kate Sheridan March 29, 2019

Reprints
Microbiome illo
Adobe

CAMBRIDGE, Mass. — As more pivotal clinical trials for microbiome-based therapies begin, some people are already asking where these drugs might go next.

One set of experts speaking at MassBio’s annual meeting on Thursday thought they had the answer — actually, two answers.  

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Kate Sheridan

Kate Sheridan

Research Reporter

Kate collects and analyzes documents, data, and other information for biotech, health tech, science, and politics stories.

Tags

23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
When women are denied an abortion, their children fare…
When women are denied an abortion, their children fare worse than peers
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Why the world’s smallest wheelchairs are going unused
Why the world’s smallest wheelchairs are going unused
Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Strengthen science by funding living evidence synthesis
Strengthen science by funding living evidence synthesis

Recommended Stories